An August 2025 FDA Warning Letter to a U.S. device manufacturer (not named here) put a spotlight on water systems, sampling methods, and documentation. The takeaways map neatly to what hospitals must do for ANSI/AAMI ST108 and related quality expectations: sample the way you actually use the water, control and document sanitization (including residuals), monitor under “real” production conditions, and escalate when data drift.
Why this matters to Sterile Processing
Water quality isn’t just a facilities concern—it’s an SPD outcome driver. Auditors increasingly expect evidence that your water system is controlled, representative of real-world use, and supported by data that trigger action when limits are exceeded. The Warning Letter below offers a clear, transferable lesson plan for hospitals.
What the auditors flagged (translated for hospitals)
1) Sampling must mirror real use
Issue observed: Sampling through non-POU pathways that doesn’t occur during routine production.
Hospital lesson: If staff use water at the sink or equipment connection, sample at that actual point of use (POU) and under normal conditions. Avoid “polishing” the sample. Your SOPs should match real practice.
2) Sanitization changes require change control and residual checks
Issue observed: A switch in sterilant/sanitant without documented change control, biocompatibility/risk assessment, or a plan to test for residual sanitant; missing documentation that the system was residual-free before release.
Hospital lesson: If you change chemicals, concentrations, or procedures, run a formal change control: supplier notification/qualification, risk & biocompatibility impact, validated method for residual detection, limits, and release criteria. Keep proof that the system is free of residuals before use.
3) Environmental monitoring must be “in-process,” not staged
Issue observed: Cleaning before taking surface swabs, minimizing personnel traffic during air sampling, and unclear timing for non-viable sampling—yielding non-representative results.
Hospital lesson: Sample during normal operations (people moving, equipment running). Don’t “prep” the environment to look better than reality. Define when you sample (start-up, peak, mid-shift) and what triggers escalation.
4) Bioburden monitoring needs rationale and escalation rules
Issue observed: A fixed calendar frequency without a documented basis; multiple out-of-spec events with no increase in frequency or formal evaluation; minimal attention to raw-material/packaging contributions.
Hospital lesson: Set monitoring frequency based on risk and trend data, with explicit alert/action limits that increase frequency and initiate CAPA when exceeded. Consider upstream contributors: incoming water quality, storage, and distribution plumbing.
How this maps to ANSI/AAMI ST108 expectations
While the Warning Letter targeted a manufacturer, the control concepts echo ST108:
Representative sampling at the POU → Don’t sanitize/flush in ways staff won’t do during normal use.
Defined limits and actions → Set specs (e.g., conductivity/resistivity, TOC, endotoxin, microbiological counts) with pre-set escalation paths.
Validated sanitization with residual control → If you sanitize distribution loops, verify no residuals remain; document method, acceptance criteria, and results.
In-process environmental verification → Monitor under realistic load and traffic.
Documentation & training → SOPs must match practice; training records must match SOPs; audits expect both.
Quick self-check: Are you audit-ready?
POU sampling = reality check: Are your sampling points identical to where staff draw water?
No pre-cleaning before sampling: Do your SOPs forbid “extra” cleaning steps that mask true conditions?
Sanitization change control: Any recent chemical/procedure changes fully documented, risk-assessed, and trained?
Residual sanitant program: Do you have a validated test and acceptance criteria to confirm before release?
Defined specs & actions: Are conductivity, microbiological limits, etc. documented with alert/action thresholds?
Escalation rules: If an action level is exceeded, does frequency automatically increase and does corrective action plan initiate?
Environmental sampling during operations: Are viable/non-viable air and surfaces sampled with people/equipment active?
Traceability: Can you link each sample to a location, time, operator, and lot/instrument set impact?
Training parity: Do staff do exactly what the SOP says (and can you prove it)?
Trend reviews: Do you trend quarterly at minimum—and does leadership see the trends?
What “good evidence” looks like to an auditor
Latest SOPs that explicitly require representative POU sampling and prohibit non-routine pre-cleaning.
Sampling maps with labeled POUs and frequencies.
Sanitization records with control, verification before release, and training logs.
Monitoring logs (conductivity, etc.) with reports and documented responses to alerts/actions.
Records showing effectiveness checks and routine completion.
How VERDA helps—without the sales pitch
Reality-based sampling plans: We align sampling with true points of use and typical workflow—no “audit theater.”
Residuals & sanitization controls: We validate residual-sanitant methods, set limits, and build release criteria into your routine.
Dynamic environmental monitoring: We design in-process viable/non-viable programs with clear timing and escalation.
Actionable trending: Dashboards that flag drift early (conductivity, etc.) and suggest next steps.
Audit-ready documentation: SOPs that match practice, training records, and templates with effectiveness verification.
Bottom line: If your water program looks good only on paper, auditors will find it. Make your sampling, sanitization, and monitoring reflect real use—and let your data drive action.
Notes & privacy
This post summarizes themes from an actual public Warning Letter published in August 11, 2025 without identifying the company, facility, or product. It is provided for educational purposes to help hospitals strengthen water quality programs aligned with ANSI/AAMI ST108 and broader quality expectations.